Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES1 | P23141 | 2/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.47 |
| ▸ | CES2 | O00748 | 1/20 | 0.47 |
| ▸ | BCHE | P06276 | 1/20 | 0.47 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.47 |
| ▸ | DNMT1 | P26358 | 2/20 | 0.42 |
| ▸ | CASP1 | P29466 | 2/20 | 0.42 |
| ▸ | CASP7 | P55210 | 2/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
| ▸ | PABPC1 | P11940 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.40 |
| ▸ | RAB9A | P51151 | 3/20 | 0.40 |
| ▸ | MAOB | P27338 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 4/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.40 |
| ▸ | MAPT | P10636 | 3/20 | 0.40 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.40 |
| ▸ | ADORA2A | P29274 | 2/20 | 0.40 |
| ▸ | ADORA1 | P30542 | 2/20 | 0.40 |
| ▸ | LMNA | P02545 | 2/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1923716 | 0.81 | ALDH1A1 (0.45) | CES1ALDH1A1DNMT1CASP1CASP7 | |
| SCHEMBL2346874 | 0.79 | ALDH1A1 (0.53) | CES1ALDH1A1CASP1CASP7KDM4E | |
| SCHEMBL29270351 | 0.79 | CES1 (0.50) | CES1ALDH1A1CES2BCHEMCL1 | |
| SCHEMBL31000361 | 0.79 | CES1 (0.50) | CES1ALDH1A1CES2BCHEMCL1 | |
| SCHEMBL2138002 | 0.76 | CES1 (0.43) | CES1ALDH1A1DNMT1CASP1CASP7 | |
| SCHEMBL4939013 | 0.76 | CES1 (0.46) | CES1ALDH1A1DNMT1CASP1CASP7 | |
| SCHEMBL29268744 | 0.74 | CES1 (0.44) | CES1ALDH1A1MCL1DNMT1CASP1 | |
| Acenaphthoquinone SCHEMBL19212172 | 0.74 | ALDH1A1 (0.77) | CES1ALDH1A1CES2BCHEMCL1 | |
| SCHEMBL2156357 | 0.74 | CES1 (1.00) | CES1ALDH1A1CES2BCHEMCL1 | |
| SCHEMBL10015442 | 0.74 | CES1 (0.57) | CES1ALDH1A1CES2BCHEMCL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9028976-B2 | Organic EL device | FUTABA CORPORATION (JP) | 2015-05-12 | — | — | US | disclosed |
| US-20110295017-A1 | Organic EL Device | TDK CORPORATION (JP) | 2011-12-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110295017-A1 | Organic EL Device | LEF1, ELP1, MLLT1 | CES1 2544/4885ALDH1A1 327/4885CES2 252/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.